formaldehyde has been researched along with 4-iodo-2,5-dimethoxyphenylisopropylamine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Goto, F; Ishizaki, K; Obata, H; Sasaki, M | 1 |
Donishi, T; Imbe, H; Kimura, A; Okamoto, K; Senba, E; Tamai, Y | 1 |
Barragán-Iglesias, P; Bravo-Hernández, M; Cervantes-Durán, C; Granados-Soto, V; Pineda-Farias, JB; Quiñonez-Bastidas, GN; Vidal-Cantú, GC | 1 |
3 other study(ies) available for formaldehyde and 4-iodo-2,5-dimethoxyphenylisopropylamine
Article | Year |
---|---|
Effects of 5-HT2 and 5-HT3 receptors on the modulation of nociceptive transmission in rat spinal cord according to the formalin test.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Amphetamines; Animals; Dose-Response Relationship, Drug; Formaldehyde; Injections, Spinal; Male; Nociceptors; Pain; Pain Measurement; Pyridines; Pyrroles; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT1B; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Receptors, Serotonin, 5-HT3; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Spinal Cord; Synaptic Transmission; Tropanes | 2001 |
Activation of central 5HT2A receptors reduces the craniofacial nociception of rats.
Topics: Action Potentials; Amphetamines; Animals; Behavior, Animal; Disease Models, Animal; Drug Interactions; Facial Pain; Formaldehyde; Functional Laterality; Ketanserin; Male; Neurons; Nociceptors; Oncogene Proteins v-fos; Pain Measurement; Physical Stimulation; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Serotonin Antagonists; Serotonin Receptor Agonists; Trigeminal Nucleus, Spinal | 2007 |
Evidence for the participation of peripheral 5-HT₂A, 5-HT₂B, and 5-HT₂C receptors in formalin-induced secondary mechanical allodynia and hyperalgesia.
Topics: Amphetamines; Analgesics; Animals; Dose-Response Relationship, Drug; Female; Fluoxetine; Formaldehyde; Hyperalgesia; Ketanserin; p-Methoxy-N-methylphenethylamine; Pyrimidines; Rats, Wistar; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2B; Receptor, Serotonin, 5-HT2C; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Spiro Compounds; Sulfonamides | 2013 |